Answers from the Lab

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss the latest in infectious disease outbreaks.     Specific topics of discussion include: Recent trends in the spread of H5 bird flu and dengue fever.  Why it’s importa...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss how labs can enhance patient access to improve health equity. Specific topics of discussion include: Innovations creating new possibilities, such as mobile clinics,...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by genetic counselors Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC, to discuss how family medical history can inform genetic testing strategies.    Specific topics of discussion include: The seven main types of genetic testing, and how clinic...

John Logan Black, M.D., explains how Mayo Clinic Laboratories' UGT1A1 tests (Mayo IDs: U1A1Q and UGTFZ ) identify genetic variants that increase the risk of potentially life-threatening reactions to irinotecan, a chemotherapy agent. (00:32) Could you give us a brief overview about your background and yourself?   (02:16) Could you explain the role of the UGT1A1 gene and its significance in the phar...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss recent outbreaks in vaccine-preventable diseases.   Specific topics of discussion include: Recent increases in outbreaks of infectious diseases, such as pertussis, m...

While confirmed cases for many respiratory illnesses are currently low, they will almost certainly spread as we move further into fall and winter. Now is the perfect time to prepare and take steps to protect yourself from everything from COVID-19 and influenza to RSV and the common cold.  In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiol...

Megan Hoenig, M.S., M.P.H., CGC, explains how Mayo Clinic Laboratories' unique hypermethylation analysis (Mayo ID: MLHPB ) provides critical adjunct information for managing Lynch syndrome. That genetic condition increases patients' risk for many kinds of cancer. Speaker 3: (00:32) Could you provide our listeners with a little bit about yourself and your background?   Speaker 3: (01:27)  Could you...

From cyberattacks to utility failures, technology disruptions are a growing risk in an increasingly digitized and automated laboratory environment. Planning for technology disruptions positions laboratories to embrace the full power of automation, artificial intelligence , and digitization while still meeting critical patient care needs during an outage.  In this episode of “Answers From the Lab,”...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Alicia Algeciras-Schimnich, Ph. D., a professor of laboratory medicine and pathology at Mayo Clinic and co-director of the Clinical Immunoassay Laboratory. They discuss Mayo Clinic’s plasma test for detecting Alzheimer’s disease and how it supports increase...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Dong Chen, M.D., Ph. D., chair of the Division of Hematopathology in the Department of Laboratory Medicine and Pathology at Mayo Clinic. They discuss rare and inherited platelet disorders and esoteric laboratory testing of hematologic disorders. Specific to...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories. They discuss the latest news in pathogen activity and how these viruses serve as an important reminder of the role of the public-private lab partnership. Their discussion includ...

Matthew Schultz, Ph. D., and Amy White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD ) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD -related peripheral neuropathy is fairly common. (00:31) Would you share a little bit about yourself and your background?   (01:11)  Could you provide us with an overview of...

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, is joined by special guest Donald Thomas, M.D., a rheumatologist and lupus researcher. They discuss how Mayo Clinic Laboratories’ suite of innovative lupus testing , offered in collaboration with Progentec Diagnostics , is enhancing the care and quality of life for patients af...

John Mills, Ph. D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating autoimmune conditions. Show notes Speaker 3: (00:32)  Would you provide a little background on yourself, Dr. Mills?   Speaker 3: (01:19)  Dr. Dubey?   Speaker 3...

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, is joined by special guests Bernard Rubin, D.O., MPH, chief medical officer of Progentec Diagnostics, and Melissa Munroe, M.D., Ph. D., chief scientific officer and principal investigator of Progentec Diagnostics. They discuss Mayo Clinic Laboratories’ suite of innovative lupu...

Ann Moyer, M.D., Ph. D., explains how Mayo Clinic Laboratories' unique genetic tests identify patients at high risk of severe reactions to fluoropyrimidines — a type of chemotherapy drug. Test results can guide clinical decision-making for safer cancer treatment. Speaker 3: (00:32)  Would you tell us a little bit about yourself and your history with this testing?   Speaker 3: (01:25)  Would you te...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, to discuss the latest advancements in Alzheimer’s disease testing and treatment. Their discussion includes: Why there is an increased focus on Alzheimer’s disease in the diagnos...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories. They cover current trends, pain points, and opportunities for growth in the lab and diagnostics market. Their discussion includes: Insights from Dr. Morice’s participation in an...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph. D., professor of laboratory medicine and pathology and clinical virologist at Mayo Clinic. They discuss the upsurge of mpox cases, particularly in Africa, and why the World Health Organization has declared it a public health emergency...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories. They discuss what’s new and ongoing with pathogens and infections. Their discussion includes: Summer cases of COVID-19. H5N1 (avian influenza) activity and testing options. Incr...

Maria Alice Willrich, Ph. D., and Melissa Snyder, Ph. D., explain how Mayo Clinic Laboratories' unique risankizumab panel measures levels of both that drug and its antibodies in patients' blood. The results can better guide the management of patients with inflammatory bowel disease. Speaker 4: (00:32)  Please give the audience a little information about yourself and your background.   Speaker 4: (...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories. They discuss insights from Dr. Morice’s recent travels abroad, including biomanufacturing, diagnostics, cybersecurity, and supply chain activities. Their discussion includes: Wh...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph. D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to discuss the increase of dengue cases in the United States and around the world. Specific topics of discussion include: The characteristics and symptoms of dengu...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories. They discuss how healthcare is a logical space to apply artificial intelligence (AI) technology and trends in how AI is being utilized. Their discussion includes: The benefits a...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories. They discuss a case that was recently overturned by the Supreme Court of the United States that may have ramifications for the healthcare industry, including impacts on regulato...